GleamWall
中文EN

CNMD CONMED Corp

Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 816956 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.2%
TTM net income YoY-64.5%
TTM EPS YoY-64.5%
Revenue 3-yr CAGR9.6%
Net income 3-yr CAGR—

Margins

Gross margin54.6%
Operating margin7.5%
Net margin3.4%
FCF margin11.0%
EBITDA margin8.7%

Returns

ROE4.7%
ROA2.0%
ROIC (approx.)3.7%
Asset turnover0.59x

Leverage & solvency

Liabilities / assets55.6%
Debt / equity0.81x
Current ratio2.14x
Interest coverage3.30x

Cash quality & payout

Operating cash flow / net income3.63x
Accruals ratio-5.3%
Payout ratio52.6%
Capex / revenue1.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-30
Income statement
Revenue$335.56M$343.49M$373.20M$337.93M$342.35M$321.26M$345.94M$316.70M
Cost of revenue$146.41M$146.03M$154.91M$171.81M$154.03M$143.50M$147.60M$137.71M
Gross profit$189.15M$197.46M$218.28M$166.12M$188.32M$177.75M$198.34M$179.00M
R&D expense$15.59M$15.50M$14.90M$13.90M$14.14M$12.95M$13.18M$13.56M
SG&A expense$136.42M$145.55M$166.76M$140.34M$136.02M$148.85M$132.67M$99.73M
Operating income$37.14M$36.41M$36.62M$11.88M$38.16M$15.96M$52.50M$65.71M
Interest expense$11.13M$7.88M$7.37M$7.61M$7.82M$8.29M$8.86M$9.25M
Pretax income$26.01M$31.35M$29.25M$4.27M$29.92M$7.67M$43.64M$56.45M
Income tax$6.21M$8.28M$12.51M$1.41M$8.50M$1.64M$9.89M$7.47M
Net income$19.80M$23.07M$16.74M$2.86M$21.42M$6.04M$33.76M$48.98M
EBITDA$41.12M—$40.69M$16.25M$42.63M$20.19M$56.70M$69.90M
EPS (basic)0.660.77—0.090.690.19—1.59
EPS (diluted)0.660.77—0.090.690.19—1.57
Dividends declared per share——-0.000.200.200.200.200.20
Weighted avg. shares (diluted)30.12M30.12M—31.05M31.05M31.15M—31.11M
Balance sheet
Cash & equivalents$47.97M$37.33M$40.82M$38.93M$33.94M$35.48M$24.46M$38.47M
Receivables$233.91M$239.77M$247.83M$224.94M$234.15M$221.14M$237.73M$231.23M
Inventory$362.83M$360.18M$355.54M$364.36M$362.25M$354.68M$346.72M$342.55M
Current assets$682.04M$675.66M$672.86M$662.16M$657.78M$639.00M$640.01M$641.00M
PP&E, net$108.77M$110.14M$113.33M$112.04M$116.86M$116.06M$115.79M$117.42M
Goodwill$796.93M$796.90M$807.01M$806.92M$806.93M$805.70M$805.36M$806.87M
Intangibles$556.63M$564.42M$582.05M$593.11M$601.82M$609.83M$617.66M$625.57M
Total assets$2.30B$2.30B$2.33B$2.32B$2.33B$2.30B$2.31B$2.32B
Current liabilities$458.96M$455.40M$315.04M$314.70M$294.84M$283.15M$278.13M$282.31M
Short-term debt$180.11M$177.20M$712,000$746,000$714,000$714,000$715,000$717,000
Long-term debt$635.76M$657.05M$834.23M$853.01M$881.11M$891.44M$905.07M$940.09M
Total debt$815.87M$834.25M$834.94M$853.75M$881.83M$892.16M$905.78M$940.81M
Total liabilities$1.24B$1.26B$1.29B$1.31B$1.33B$1.32B$1.34B$1.38B
Shareholders' equity$1.06B$1.04B$1.03B$1.01B$1.00B$977.64M$962.68M$932.90M
Net debt$767.89M$796.92M$794.12M$814.82M$847.89M$856.67M$881.32M$902.34M
Cash flow statement
Operating cash flow$49.41M—$46.34M$53.69M$29.13M$41.53M$43.34M$51.20M
Capital expenditure$2.68M—$5.11M$5.19M$5.73M$3.78M$4.04M$3.42M
Free cash flow$46.73M—$41.22M$48.50M$23.41M$37.76M$39.30M$47.78M
Investing cash flow-$1.87M—-$7.11M-$5.19M-$5.73M-$2.93M-$4.04M-$3.42M
Financing cash flow-$36.96M—-$37.37M-$43.52M-$26.53M-$28.40M-$51.07M-$38.83M
Depreciation & amortization$3.98M—$4.07M$4.38M$4.47M$4.24M$4.20M$4.20M
Stock-based compensation$5.91M$5.23M$4.97M$4.58M$4.90M$13.86M$6.22M$6.12M
Dividends paid$0—$6.19M$6.19M$6.19M$6.18M$6.18M$6.16M
Share buybacks$6.20M——$0————

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.